Terrance P. Coyne
EVP & CFO · 5 filings · Latest: May 26, 2026
Royalty Pharma plc
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
RPRX | Terrance P. Coyne | EVP & CFO | May 26, 2026 | Sale | $53.98 | 64,399 | $3.5M | 0 | |
RPRX | Terrance P. Coyne | EVP & CFO | May 6, 2026 | Grant/Award | $0.00 | 24,263 | — | 64,399 | |
RPRX | Terrance P. Coyne | EVP & CFO | Apr 28, 2026 | Sale | $49.78 | 34,791 | $1.7M | 40,136 | |
RPRX | Terrance P. Coyne | EVP & CFO | Apr 1, 2026 | Sale | $48.33 | 34,791 | $1.7M | 32,916 | |
RPRX | Terrance P. Coyne | EVP & CFO | Mar 23, 2026 | Sale | $45.53 | 34,791 | $1.6M | 43,886 |